Skip to main content

For informational and research purposes only.

Medical DisclaimerTerms of Use

Marshmallow Root: The Definitive Guide

EMA accepts traditional demulcent use for dry cough and mild digestive discomfort, while describing the clinical evidence as insufficient for well-established use.

The source-backed protocols describe root material and traditional use; clinical trials remain too weak for confident efficacy claims.
Published by DoserlyUpdated Next scheduled review: January 20277 min readHow this guide was made
In this guide

What is marshmallow root?

Marshmallow root is the dried root of Althaea officinalis. Its water-soluble polysaccharides form mucilage. EMA’s final monograph treats specified oral and digestive uses as traditional use, meaning plausibility and long-standing exposure rather than efficacy established by robust trials.

Cold macerates, teas, syrups, drops, solid preparations and ethanol extracts are not interchangeable. Keep the exact preparation, drug-to-extract ratio, solvent, amount and age restriction attached to each protocol.

Typical Marshmallow Root Protocols

EMA source regimens, not personal recommendations. Age, preparation and indication remain attached. [1][2]
Source and contextMaterialAmountFrequencyDurationObserved result
EMA 2016 · dry cough or throat irritationComminuted root in 150 mL water as a macerate0.5–3 g per administrationSeveral times daily; maximum 15 g/dayIf symptoms last over 1 week, seek reviewTraditional-use monograph; no well-established-use classification
Adolescents, adults and older adults. Pediatric schedules are age-specific and should not be inferred from the adult row.
EMA 2016 · mild gastrointestinal discomfortComminuted root in 150 mL water as a macerate3–5 g per administration3 times daily; maximum 15 g/dayIf symptoms last over 2 weeks, seek reviewTraditional-use monograph; not a controlled efficacy estimate
Adults and adolescents over 12 years; ethanol-extract preparations have narrower age conditions.
EMA assessment · clinical observationsSyrups or drops; preparation details incompleteStudy-specific or inadequately describedStudy-specificShort-termCough improved in uncontrolled pediatric studies and one small adult report
About 900 children lacked a comparator; the 63-adult placebo report did not adequately characterize the herbal preparation.

No RDA, AI or UL exists. EMA schedules apply only to the listed herbal substances or preparations and indications.

Root identity
Record Althaea officinalis root, not leaf or a candy product.
Preparation
Distinguish cold macerate, syrup, drops, solid extract and ethanol extract.
Per administration
Keep grams per 150 mL separate from the daily maximum.
Medicine interval
Record the pharmacist-approved separation from oral medicines.

Preparation is part of the exposure

1 · IDENTITY
Althaea officinalis
Root, amount and botanical quality.
2 · PREPARATION
Water + time
A macerate is not equivalent to syrup or ethanol extract.
3 · CONCLUSION
Traditional use
Plausibility and history, with clinical evidence still insufficient.
Keep material, amount, water, frequency, age and indication together.
Preparation determines mucilage exposure; traditional-use status and clinical efficacy are separate conclusions. Sources: EMA monograph · EMA assessment.

What is marshmallow root commonly used for?

The best-defined uses are soothing oral or pharyngeal irritation with associated dry cough and mild digestive discomfort. EMA considers these traditional uses. Persistent cough, shortness of breath, fever, blood, weight loss, trouble swallowing or significant abdominal pain needs assessment.

Which forms and labels matter?

Look for Althaea officinalis, root, amount per administration, water volume, extract ratio and solvent. Sugar content matters in syrups. Alcohol-containing preparations have different age restrictions. A multi-herb cough syrup cannot establish a marshmallow-root-specific effect.

What does the human evidence show?

EMA reviewed two observational studies of marshmallow-root syrup involving around 900 children with mouth or throat irritation and dry cough. Cough appeared to improve, but the studies had no comparator, so spontaneous recovery, co-care and reporting effects could not be separated. [2]

The assessment also describes 63 adults with dry cough in whom marshmallow-root drops appeared better than placebo. EMA judged the preparation insufficiently described and therefore did not base well-established use on that result. [2]

The final monograph consequently rests on at least 30 years of medicinal use, including at least 15 years in the EU. That traditional-use pathway is meaningful regulatory context, but it is not equivalent to a modern replicated efficacy program. [1][2]

How might it work?

Hydrated mucilage creates a viscous layer and can prolong local contact with irritated tissue. This is a plausible demulcent mechanism. It does not establish an anti-inflammatory, antimicrobial or reflux-treatment effect in humans.

What are the risks and interactions?

Allergy and gastrointestinal intolerance are possible. Because clinical safety reporting is sparse, absence of listed adverse effects in an older monograph should not be read as proof that every preparation is risk-free.

Mucilage may delay absorption of oral medicines. Ask a pharmacist about spacing, particularly for narrow-therapeutic-index drugs. EMA does not recommend pregnancy or breastfeeding use because adequate data are absent; LactMed likewise reports no maternal or infant clinical data. [1][3]

Status in the United States and Canada

In the United States, supplements are not approved drugs for cough or gastrointestinal disease. In Canada, check the product’s NPN and its exact conditions. EMA’s EU monograph does not authorize a North American product.

What should be monitored?

Record product and lot, plant part, preparation, grams or millilitres per administration, water volume, daily total, medicine interval, cough frequency, throat irritation, digestive symptoms, allergy and reason for stopping.

What happens after stopping?

No withdrawal syndrome or taper is established. A local soothing sensation may disappear after stopping; persistent symptoms need reassessment.

How should it be stored?

Keep root dry, sealed and away from heat and moisture. Prepare water macerates hygienically and follow the product’s storage and discard instructions.

Community experiences

Anecdotes often omit the plant part, extraction solvent, sugar, co-ingredients and natural resolution of a cough. A coating sensation is exposure information, not proof that an infection or digestive disorder has been treated.

How does it compare with other approaches?

Marshmallow root is a traditional demulcent. Honey, hydration, diagnosis-specific therapy and other cough or digestive treatments have different evidence and age restrictions. The correct comparison depends on the cause of the symptom.

Frequently asked questions

Is EMA approval proof that it works?

No. EMA explicitly classifies the uses as traditional, based on long-standing use with insufficient clinical-trial evidence for well-established use. [1][2]

What adult cough amount does EMA list?

0.5–3 g of comminuted root in 150 mL water as a macerate several times daily, up to 15 g/day. [1]

What is the digestive schedule?

3–5 g in 150 mL water three times daily, maximum 15 g/day, for adults and adolescents over 12. [1]

Can the pediatric observations prove benefit?

No. They lacked a comparator and cannot separate treatment from natural recovery. [2]

Can it be taken with medicines?

Do not assume so. Ask a pharmacist about an interval because mucilage may alter absorption.

Is it established during breastfeeding?

No maternal or infant clinical data were located. [3]

Glossary

Terms used in this guide.

Mucilage
Water-swellable plant polysaccharides that form a viscous gel.
Macerate
Preparation made by soaking botanical material in a liquid.
Traditional use
Regulatory pathway based on long-standing medicinal use and plausibility rather than sufficient clinical trials.
Demulcent
Material intended to soothe by coating or local contact.
Well-established use
EMA category requiring a stronger published evidence basis than traditional use.

How this guide was researched

This guide prioritizes the final EMA monograph and its assessment report, then uses LactMed for the narrow breastfeeding evidence boundary. Sources were checked October 9, 2026.

How this guide was made

Method and evidence gaps

The EMA monograph and assessment report were read for preparation-specific doses, age limits, duration triggers and the committee’s evidence judgment. The assessment’s pediatric observations lacked comparators and the adult report inadequately described the preparation. LactMed was used only for lactation uncertainty.

Gaps: replicated controlled trials, standardized products, interaction studies, pregnancy, lactation, long-term safety and product equivalence.

Sources

Read the final monograph with its assessment report; use LactMed only for the lactation-data boundary.

Showing 3 sources

  1. 01

    European Union herbal monograph on Althaea officinalis L., radix ↗

    Final European Union traditional-use monograph

    Preparation-specific doses, age conditions, symptom-duration triggers and traditional-use indications.

  2. 02

    Assessment report on Althaea officinalis L., radix ↗

    Regulatory evidence assessment

    Explains why pediatric observations and the poorly characterized adult study did not establish well-established use.

  3. 03

    Marshmallow ↗

    Institutional lactation evidence summary

    No maternal or infant clinical data; product composition and quality may vary.